Aveanna Healthcare Holdings, Inc. Stock Price, News & Analysis

Aveanna Healthcare (NASDAQ: AVAH) has announced its participation in the upcoming RBC 2025 Global Healthcare Conference in New York on May 20, 2025. The company's management team will engage in two key activities during the event:

• One-on-one meetings with investors
• A fireside chat scheduled for 11:30 a.m. Eastern Time

Interested parties can access a live webcast of the presentation through Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a limited time following the event.

Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. The company's management team will engage in two key activities:

1. Host one-on-one investor meetings

2. Deliver a presentation at 3:15 PM Pacific Time

Investors and interested parties can access the presentation through a live webcast on Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a time after the event.

Aveanna Healthcare Holdings (NASDAQ: AVAH) has scheduled its first quarter 2025 earnings release and conference call. The company will announce Q1 results before market open on Thursday, May 8, 2025, followed by a conference call at 10:00 a.m. Eastern Time.

Investors can access the call via phone (1-877-407-0789 for domestic, 1-201-689-8562 for international) or webcast through the company's Investor Relations website. A replay will be available for one week online and until May 15 via phone (1-844-512-2921 domestic, 1-412-317-6671 international) using passcode 13752435.

Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced an agreement to acquire Thrive Skilled Pediatric Care, one of the largest independent pediatric home care providers. The acquisition, expected to close in Q2 2025, will expand Aveanna's presence across seven states, including two new markets.

Thrive SPC operates 23 locations across Arizona, Georgia, Kansas, New Mexico, North Carolina, Virginia, and Texas, primarily offering Private Duty Nursing services along with Pediatric Therapy, Licensed Health Aide Services, and Certified Nurse Assistant Services.

The transaction will be funded through a combination of common stock shares and cash from Aveanna's balance sheet. Edge Healthcare Partners and Bass, Berry & Sims served as Aveanna's advisors, while Cantor Fitzgerald & Co. and Ropes & Gray LLP represented Thrive SPC.

Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q4 2024 financial results, with revenue increasing 8.6% to $519.9 million compared to Q4 2023. The company achieved significant improvements with a net income of $29.2 million, contrasting with a $25.7 million loss in the prior year period.

Key Q4 metrics include a 15.7% increase in gross margin to $171.7 million and a 42.8% rise in Adjusted EBITDA to $55.2 million. For the full year 2024, revenue reached $2.02 billion, up 6.8% from 2023, while Adjusted EBITDA grew 31.9% to $183.6 million.

Looking ahead, Aveanna provided 2025 guidance projecting revenue between $2.10-2.12 billion and Adjusted EBITDA between $190-194 million. The company maintains a strong liquidity position with $84.3 million in cash and additional borrowing capacity through various facilities.

Aveanna Healthcare Holdings (NASDAQ: AVAH) has scheduled its fourth quarter and full year 2024 earnings release for Thursday, March 13, 2025, before market open. The company will host a conference call at 10:00 a.m. Eastern Time on the same day.

Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (International). A replay will be available for one week until March 20, 2025, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (International) using passcode 13750192. Additionally, a simultaneous webcast will be available on the company's Investor Relations website at ir.aveanna.com.

Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management team will deliver a presentation on January 15, 2025 at 10:30 a.m. PST, followed by one-on-one investor meetings throughout the day.

Investors and interested parties can access a live webcast of the presentation through Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a time after the event.

Aveanna Healthcare Holdings reported strong Q3 2024 financial results with revenue of $509.0 million, up 6.5% year-over-year. Gross margin increased 8.4% to $159.7 million, while net loss improved to $42.8 million from $102.4 million in Q3 2023. Adjusted EBITDA grew 32.2% to $47.8 million. The company raised its full-year 2024 guidance, projecting revenue of approximately $2.0 billion and Adjusted EBITDA greater than $168 million. The improved performance was attributed to better payor rates and successful cost reduction efforts.